AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Sonographic Examination of Median Nerve Variations

Recruitingn/aAges 18 Years - 65 YearsAllYunus Burak Bayฤฑr
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The aim of the study is to evaluate the prevalence of bifid median nerve in patients diagnosed with carpal tunnel syndrome (CTS) and whether it has a higher prevalence in CTS patients than in asymptomatic individuals, and to evaluate the characteristics of the bifid median nerve found and whether median nerve variations are predisposing factors in the development of CTS.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Having typical Carpal Tunnel Sydnrome symptoms lasting longer than 3 months * Carpal tunnel syndrome diagnosed with EMG * Being a male/female \>18 years of age Exclusion Criteria: * History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome, or surgery in the wrist area * Presence of inflammatory arthritis, hypothyroidism, pregnancy, rheumatological disorders, diabetes mellitus * Presence of peripheral vascular disease
๐Ÿ’Š

What it tests

  • elastography,usg
๐Ÿ“

Where

1 site
Etlik City Hospital
Ankara, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy